13.52Open10.74Pre Close2 Volume4 Open Interest65.00Strike Price2.70KTurnover152.63%IV0.56%PremiumNov 29, 2024Expiry Date13.09Intrinsic Value100Multiplier2DDays to Expiry0.44Extrinsic Value100Contract SizeAmericanOptions Type0.9580Delta0.0103Gamma5.72Leverage Ratio-0.1477Theta0.0033Rho5.48Eff Leverage0.0051Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet